Brivaracetam (All indications)

Exposed non-exposed studies (cohort)

Study Country
Study period
Population source Exposure definition Non-exposure definition Sample size Rmk
Battino (Epilepsy), 2024 Worldwide (47 countries)
1999 - 2022
Pregnant women with epilepsy exposed to antiseizure medications at the time of conception and enrolled within the 16th week of gestation, where fetal outcome had not yet been determined. Pregnant women with epilepsy exposed to Brivaracetam monotherapy at the time of conception. exposed to other treatment, sick
Pregnant women with epilepsy exposed to lamotrigine monotherapy at the time of conception.
2 / 3584
The NAAED (Indications NOS) (Controls exposed to LTG), 2024 North America and Canada
1997 - 2023
Pregnant women who are taking an antiepileptic drug for any reason and had a liveborn infant, a stillborn infant, or a pregnancy terminated because of a fetal abnormality and enrolled as 'pure' or 'traditional' enrollees. Infants of pregnant women who used Brivaracetam as monotherapy, during the first trimester. (This is a subgroup of exposure among the whole exposed group considered in the study). exposed to other treatment, sick
Infants of pregnant women who used lamotrigine as monotherapy, during the first trimester.
15 / 2461 Data extracted from the publication Perucca 2024, an update of the Epilepsy-pregnancy registries.
The NAAED (Indications NOS) (Controls unexposed, disease free), 2024 North America and Canada
1997 - 2023
Pregnant women who are taking an antiepileptic drug for any reason and had a liveborn infant, a stillborn infant, or a pregnancy terminated because of a fetal abnormality and enrolled as 'pure' or 'traditional' enrollees. Infants of pregnant women who used Brivaracetam as monotherapy, during the first trimester. (This is a subgroup of exposure among the whole exposed group considered in the study). unexposed, disease free
Infants of pregnant women, not taking an antiepileptic drug and without epilepsy, who were recruited from among the friends and family members of the enrolled women taking an antiepileptic drug.
15 / 1311 Data extracted from the publication Perucca 2024 (for exposed pregnancies) and the North American AED pregnancy registry website (for controls).

Case-control studies (cohort)

Study Country
Study period
Case Control Sample size Rmk

master protocol